Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells

Scandinavian Journal of Immunology

Volumn 51, Issue 4, 2000, Pages 361-371

  Li, Lq ^a   Masucci, M G ^a   Levitsky, V ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIGENS, CD; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-4; INTERLEUKIN-7; MONOCYTES; RECOMBINANT PROTEINS; UP-REGULATION;

EID: 0033993644     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00687.x     Document Type: Article

References (46)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
2. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JFAP, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998;393:478-80.
3. + T-helper and a T-killer cell. Nature 1998;393:474-8.
4. Schoenberger SP, Toes REM, van der Voort EIH, Offringa R, Melief CJM. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393:480-3.
5. Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol Today 1998;19:448-54.
6. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J Exp Medicine 1994;179:1109-18.
7. Oehler L, Majdic O, Pickl WF et al. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristic. J Exp Medicine 1998;187:1019-28.
8. Paluka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 1998;160:4587-95.
9. + blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci United States America 1997;93:2588-92.
10. Varas A, Vicente A, Sacedon R, Zapata AG. Interleukin-7 influences the development of thymic dendritic cells. Blood 1998;92:93-100.
11. + pro-B cells can give rise to dendritic cells in vitro. J Immunol 1998;161:5795-9.
12. Rosenzwajg M, Canque B, Gluckman JC. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 1996;87:535-44.
13. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Medicine 1996;184:695-706.
14. + peripheral blood monocytes. J Immunol 1996;157:3850-9.
15. Wada H, Noguchi Y, Marino MW, Dunn AR, Old LJ. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc Natl Acad Sci United States America 1997;94:12557-61.
16. Saunders D, Lucas K, Ismaili J et al. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor. J Exp Medicine 1996;184:2185-96.
17. Takahashi K, Honeyman MC, Harrison LC. Dendritic cells generated from human blood in granulocyte macrophage-colony stimulating factor and interleukin-7. Human Immunol 1997;55:103-16.
18. Brown MA, Hural J. Functions of IL-4 and control of its expression. Crit Rev Immunology 1997;17:1-32.
19. Duschl A, Sebald W. Transmembrane and intracellular signalling by interleukine-4: receptor dimerization and beyond. European Cytokine Network 1996;7:37-49.
20. Venkitaraman AR, Cowling RJ. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with alhpa chain of the interleukin-7 receptor. European J Immunology 1994;24:2168-74.
21. de Sain-Vis B, Fugier-Vivier I, Massacrier C et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998;160:1666-76.
22. Sorg RV, McLellan AD, Hock BD, Fearnley DB, Hart DN. Human dentritic cells express functional interleukin-7. Immunobiology 1998;198:514-26.
23. Kröncke R, Loppnow H, Flad H-D, Gerdes J. Human follicular dentritic celss and vascular cells produce interleukin-7: a potential role for interleukin-7 in the germinal center reaction. European J Immunology 1996;26:2541-4 1996.
24. He YM, Malek TR. Interleukine-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells. J Exp Medicine 1996;1996:289-93.
25. von Freeden-Jeffry U, Vieira P, Lucían LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL) -7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Medicine 1995;181:1519-26.
26. Paterson RL, Kelleher CA, Streib JE et al. Activation of human thymocytes after infection by EBV. J Immunol 1995;154:1440-9.
27. Sinha SK, Todd SC, Hedrick JA, Speiser CL, Lambris JD, Tsoukas CD. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript. J Immunol 1993;150: 5311-20.
28. Timens W, Boes A, Vos H, Poppema S. Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells. Histochemistry 1991;95:605-11.
29. Tsoukas CD, Lambris JD. Expression of EBV/C3d receptors on T cells: biological significance. Immunol Today 1993;14:56-9.
30. Watry D, Hedrick JA, Siervo S et al. Infection of human thymocytes by Epstein-Barr virus. J Exp Medicine 1991;173:971-80.
31. r membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci USA 1984;81:881-5.
32. Liu YJ, Xu J, de Bouteiller O et al. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J Exp Medicine 1997;185:165-70.
33. Vik DP, Fearon DT. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3. Journal of Immunol 1985;134: 2571-9.
34. Kieff E. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM eds. Fields Virology. Philadelphia: Lippincott-Raven Publishers, 1996:2343-96.
35. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearson DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 1984;81:4510-6.
36. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott-Raven Publishers, 1996: 2397-446.
37. Miller G, Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 1973; 70:190-4.
38. Reedman BM, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973;11:499-520.
39. Sairenji T, Bertoni G, Medveczky MM, Medvecky PG, Nguyen QV, Humpheys RE. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. J Virol 1988;62:2614-21.
40. Schriever F, Freedman AS, Freeman G et al. Isolated human follicilar dendritic cells display a unique antigenic phenotype. Journal of Exp Med 1989;169: 2043-58.
41. Illges H, Braun M, Peter HH, Melchers I. Analysis of the human CD21 transcription unit reveals differential splicing of exon 11 in mature transcripts and excludes alternative splicing as the mechanism causing solubilization of CD21. Mol Immunol 1997;34:683-93.
42. Buelens C, Verhasselt V, de Groote D, Thielemans K, Goldman M, Willems F. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. European J Immunology 1997;27:1848-52.
43. Gallay P, Heumann D, Leroy D, Barras C, Glauser MP. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci USA 1994;91:7922-6.
44. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. Cd14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding-protein. Science 1990;249:1431-3.
45. Li Q, Spriggs MK, Kovats S et al. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 1997;71: 4657-62.
46. Gaither TA, Vargas I, Inada S, Frank MM. The complement fragment C3d facilitates phogacytosis by monocytes. Immunology 1987;62:405-11.